Filing Details
- Accession Number:
- 0001011060-13-000044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-06 12:32:32
- Reporting Period:
- 2013-12-03
- Filing Date:
- 2013-12-06
- Accepted Time:
- 2013-12-06 12:32:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011060 | Advansource Biomaterials Corp | ASNB | Surgical & Medical Instruments & Apparatus (3841) | 043186647 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1558093 | Crispino David Volpe | 229 Andover Street Wilmington MA 01887 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-03 | 2,000 | $0.05 | 132,153 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-12-03 | 8,000 | $0.05 | 140,153 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-12-03 | 10,000 | $0.05 | 150,153 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Shares acquired through open market purchase.